What we're reading, December 17, 2015: Congress is expected to pass a spending plan that includes 3 changes to the Affordable Care Act; a new analysis estimates 2016 premiums for marketplace plans will increase 11%; and one-third of Americans die from cardiovascular disease.
Republicans are making small progress in their attempt to do away with President Obama’s healthcare law. A spending plan Congress is expected to approve this week includes 3 changes to the Affordable Care Act, including a delay of the Cadillac tax, a suspension of the tax on medical devices, and limits on federal payments to insurers that lose money in the insurance marketplaces, reported The New York Times.
As for the marketplace health plans, the Robert Wood Johnson Foundation reported that monthly premiums for the silver-level plans will increase by more than 11% in 2016. USA Today reported that this increase, coupled with expected higher deductibles, could limit the number of people insured under the Affordable Care Act. The gold plans, which have higher premiums but smaller out-of-pocket costs, will see premiums increase nearly 14%, though deductibles dropped just under 1%.
One-third of Americans die from cardiovascular disease and is the number 1 killer around the world, reported United Press International. However, strides to reduce smoking, increase physical activity, and adjust diets have improved risk factors for cardiovascular disease. Still, 69% of American adults are overweight or obese and one-third say they engage in no physical activity outside of work.
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Real-World Study Reveals Key Insights Into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Gene, Light Therapy Combo Shows Promise Against Prostate Cancer Cells in Proof-of-Concept Study
April 18th 2024In their preclinical model, the researchers found efficacy both in vitro and in vivo by using CRISPR-Cas9 to mimic porphyria and combining the technology with light therapy.
Read More
Pegcetacoplan for PNH More Cost-Effective Than Anti-C5 Monoclonal Antibodies
April 18th 2024A cost-utility analysis conducted from the perspective of the Italian health system found that pegcetacoplan was more effective and less costly than 2 complement 5 (C5) inhibitors for the treatment of paroxysmal nocturnal hemoglobinuria (PNH).
Read More